By: Alana Hippensteele, Editor From: pharmacytimes.com In outpatient breast cancer clinics, oral chemotherapies are becoming more common as a treatment method for various malignancies. Yet, the hematologic (eg neutropenia) and non-hematologic (eg diarrhea) toxicities that patients experience while taking these oral chemotherapies can cause increased clinic visits, delays in treatment, and non-adherence to treatment, according to a poster presented by …
-
-
Peace for a Breast Cancer Survivor
-
What Would Motivate a Person to Action After a Breast Cancer Diagnosis
-
What’s on the Outside Doesn’t Really Matter to Many Breast Cancer Survivors
-
From a Breast Cancer Survivor: A Message to Telephone and Telemarketer Solicitors
-
Love After a Breast Cancer Diagnosis
